Dif ference between baseline induction glycaemia and glycaemia at the end of the operation was 6 ± 50 mg/dL (110 ± 45 vs 116 ± 30, p = 0.001). The following variables were identified as independent risk factors for changes in perioperative glycaemia: age > 70 years (p = 0.025), use of corticosteroids (p = 0.002) and the presence of diabetes mellitus (p < 0.001). Conclusion(s): UGIP preserved perioperative blood glucose levels within narrow limits. Risk factors for important deviation of pre-induction glycaemia were the presence of diabetes mellitus, the use of corticosteroids and age > 70 years. The statistically significant variables were included in a multiple regression analysis to identif y the independent risk factors. Results: Six teen patients (2%) developed a perioperative hyperglycaemic event. Male gender (RR = 0.34; 95% CI: 0.13 -0.90; p = 0.029), inotropic support (RR = 3.81; 95% CI: 1.40 -10.37; p = 0.01), and perioperative corticosteroids (RR = 5.83; 95% CI: 1.96 -17.30; p = 0.008) showed a significant association with such events but only corticosteroids (p = 0.006) and inotropic support (p = 0.019) were identified as independent risk factors. Thirteen patients (1.7%) developed a perioperative hypoglycaemic event. Inotropic support (RR = 4.87; 95% CI: 1.40 -17.09; p = 0.035), and diabetes mellitus (RR = 4.87; 95% CI: 1.23 -11.13; p = 0.028) showed a significant association with such events but only diabetes (p = 0.013) was identified as an independent risk factor. Conclusion: Independent risk factors for developing perioperative hyperglycaemia when using the UGIP are corticosteroids and inotropic agents, while diabetes mellitus seems to be only independent risk factor for hypoglycaemic events. This study af firms also less postoperative respiratory complications. The cost of anesthesia was similar in both groups: in control group 221DT and 192DT in UFTA group P = 0.3. The duration of ICU stay was significantly higher in control group 5.9 days± 2.5 versus 3.9 days ± 1.2 (P < 0.05). The cost of ICU stay was higher in control group: 354DT vs 234DT (P = 0.05).
Conclusion(s):
The combination of anesthesia with remifentanil and spinal analgesia with morphine and clonidine produces ef fective analgesia af ter cardiac surgery. This allows to an immediate ex tubation that can be considered as an important progress in cardiac anesthesia and that can lead to less post operative complications, an accelerating recovery, shorter ICU, shorter hospital stays that have an important benefit in terms of financial costs and resources. However, data is lacking on the impact of these protocols on high risk patients based on an objective scoring system.
4AP2-7
Utility of temporary pacing following cardiac surgery Results: 236 patients were enrolled. All had ventricular and only 142 (60%) both ventricular and atrial unipolar FEP15, Ethicon epicardial wires. The most frequent conduction disorder was type I AV block. Complete heart block on day 0 was observed in 5% of all patients (6.4% af ter valvular surgery, 10.5% af ter combined surgery and only 1.4% following on-pump coronary bypass). Temporary pacing was employed for 16% of patients on day 0, mainly for accelerating sinus or junctional bradycardia. Six patients (2.5%) required permanent device insertion (5 pacemakers, all following valvular surgery and 1 defibrillator following coronary disease). Severe complications af ter wire removal occurred in 0.8% (1 tamponade, 1 hemothora x). Discussion: Temporary epicardial pacing (TEP) is frequently used in the immediate postop period (16%), mainly for accelerating correction of bradycardia. Severe conduction disorders are more common following valvular or combined surgery. These abnormalities, mostly temporary, may sometimes require permanent pacemaker (2.5% in our study). On the contrary, patients undergoing isolated coronary bypass, even on-pump, rarely require postoperative pacing (1.4% of temporary complete heart block and no permanent pacemaker). Only 0.8% of serious complications were recorded and benefitrisk assessment seems in favour of temporary epicardial wires use, at least for valve/combined surgery. Conclusion: Given the benefits of TEP and the low incidence of severe complications, this method is still the best way to treat conduction abnormalities following valve surgery. The utility of TEPW af ter coronary bypass remains unclear.
4AP2-8
Natural evolution of temporary epicardial wires following cardiac surgery Background: Natural evolution of temporary epicardial wires thresholds following cardiac surgery is a major concern. The few publications on this subject report significant elevation of capture thresholds af ter the 4th postoperative day and significant deterioration of sensitivity af ter the 2 nd postoperative day, with no predictive factors identified.
Objectives: to prospectively investigate the natural evolution of temporary epicardial wires thresholds. Materials and Methods: observational prospective monocentric study, including all adult patients having heart surgery with epicardial wire insertion, except those undergoing transplantation or having permanent pacemakers. Thresholds were measured daily until wires removal or permanent device insertion. When used, temporary pacemaker set tings were recorded. Descriptive statistics and analysis of variance (ANOVA) method were performed with p< 0.05 as significance threshold. Results -236 patients were enrolled. All had ventricular and only 142 (60%) both ventricular and atrial unipolar FEP15, Ethicon epicardial wires. Capture thresholds increased significantly by the first (atrial wires) and by the second (ventricular wires) postoperative day. Both atrial and ventricular sensitivity deteriorated significantly by the 2 nd postoperative day. Ten percent of epicardial wires lost their capture function by the 4th postoperative day, while 17% remained functional beyond the 10th postoperative day. Temporary pacing was used for 16% of patients on day 0 with a median energy output of 17.5 mA (atrial) and 20 mA (ventricular). Discussion: In our study, evolution of temporary epicardial wires capture thresholds was dif ferent from that described in earlier studies, with significant increase by the 1st and 2 nd postoperative day until the 5th day. Two opposite profiles were also noticed: rapidly nonfunctional vs. long-lasting wires. Sensitivity evolution was similar to the literature, with significant deterioration by the 2 nd day. When required, temporary epicardial pacing applied high pacemaker energy output regardless of measured capture thresholds. This could partially explain the early significant increase of capture thresholds observed in our study. Conclusion: Temporary epicardial wires natural history appears to be insuf ficiently known. Predictive factors of dif ferent threshold evolution profiles need be identified in other prospective multicentric studies, to bet ter define epicardial wire reliability.
4AP2-9
Phosphodiesterase 3 inhibitor is associated with perioperative atrial fibrillation Omae T., Kanmura Y., Imakiire N., Yoshikawa A., Fujimoto T.
Fujimoto Hayasuzu Hospital, Dept of Anaesthesiology, Miyakonojo, Japan
Background and Goal of Study: Perioperative atrial fibrillation (PAF) is the most frequentcomplication that occurs af ter cardiovascular surgery. The incidence of cardiovascular events, such as cerebral infarction and heart failure, increases by twofold in the presence of chronic atrial fibrillation (AF). Conventional viewpoints suggest that PAF is less likely to af fect the survival of patients when compared with chronic AF, although it does slightly prolong the duration of hospital stay. However, reports suggest that PAF is associated with a significant incidence of various complications, including cardiovascular events, renal failure, infection, and cerebral infarction. Beta-blockers have been associated with a reduced the risk of developing PAF . Otherwise, inotropic drugs are commonly used perioperatively to support ventricular function. This study tested the hypothesis that the use of inotropic drugs is associated with postoperative AF .
Materials and Methods:
We evaluated perioperative risk factors in 221 patients who underwent elective coronary artery bypass graf t or valvular surgery and are in sinus rhy thm. The primary end point of the study is the occurrence of ECG-confirmed AF at any time af ter the end of surgery until hospital discharge. Patients were monitored continuously on telemetry throughout the postoperative period until discharge. Results and Discussion: Seventy-one patients (32.1%) developed AF a mean of 2.5+/-2.2 days af ter surgery. Phosphodiesterase 3 inhibitor associate with an increase risk of postoperative AF (45.6% versus 21.2% in nonusers; P< 0.001). Older age (67.3+/-8.7 versus 52.3+/-11.0 years; P< 0.001), body mass index > 30 (P=0.01), and mitral valve surgery (P=0.03) also were associated with postoperative AF . In multivariable logistic regression, age (P< 0.001), and milrinone use (odds ratio, 3.92; 95% confidence interval, 2.21 to 7.35; P< 0.001) independently predicted postoperative AF . Adding other potential confounders or stratif ying analysis by mitral valve surgery did not change the association of Phosphodiesterase 3 inhibitor use with postoperative AF .
Conclusion(s):
Phosphodiesterase 3 inhibitor is an independent risk factor for postoperative AF af ter cardiac surgery.
